| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |